HD-OPM Archive
Topics › Environment (microplastics, pollution, heat)

Small Swedish study: colesevelam lowered blood PFAS up to 38%

Gokhan Can · Nov 11, 2025 · ♥ 10 reactions · 12 comments · original Facebook post
Environment (microplastics, pollution, heat)PCSK9, ezetimibe & newer drugs
AI summary & key facts

Summarises a 10-person Swedish study of adults with high PFAS exposure: cholestyramine increased fecal PFAS excretion and a 12-week course of colesevelam reduced blood PFAS up to 38%. Authors say it was very small and observational, needs larger trials, and these drugs should not be used off-label.

A small Swedish study suggests two common cholesterol medications, cholestyramine (Questran) and colesevelam (Welchol), could help eliminate cancer-causing "forever chemicals" (PFAS) from the body. In the 10-person study of adults with high PFAS exposure, cholestyramine significantly increased the excretion of PFAS in feces, while a 12-week course of colesevelam reduced blood PFAS levels by up to 38%. These drugs are bile acid sequestrants, and scientists theorize they work by binding to PFAS in the digestive tract, preventing the chemicals from being reabsorbed. However, the researchers stressed the study was very small and observational, warning that the results need confirmation in larger trials and that people should not use these drugs off-label due to potential side effects.

  1. Serum, urinary and fecal concentrations of perfluoroalkyl substances after… (Environment International, 2025)
  1. Two $1.50 medications eliminate cancer-causing 'forever chemicals' (Daily Mail)
Paper · Environment International · 2025Serum, urinary and fecal concentrations of perfluoroalkyl substances after interventions with cholestyramine/colesevelam and probenecid – cross-over trials in Ronneby, Swedensciencedirect.com

Research cited

#cancer#cholesterol
← newer: FOURIER stroke analysis: LDL below 40 mg/dL cut major eventsolder: TARGET-D: tailored vitamin D dosing missed its main endpoint →